Safety Monitoring of Medicinal Products: Guidelines for Setting Up and Running a Pharmacovigilance Centre
(2000; 28 pages) [French]
Table of Contents
View the documentINTRODUCTION
View the document1. WHY PHARMACOVIGILANCE?
View the document2. DEFINITION AND AIMS
Open this folder and view contents3. HOW TO START A PHARMACOVIGILANCE CENTRE
Open this folder and view contents4. REPORTING OF ADVERSE DRUG REACTIONS
Close this folder5. SPECIAL ISSUES IN REPORTING
View the document5.1 Central or decentralised reporting?
View the document5.2 Stimulation of reporting
View the document5.3 Under-reporting
Open this folder and view contents6. PRACTICALITIES IN THE ORGANISATION OF A PHARMACOVIGILANCE CENTRE
Open this folder and view contents7. ASSESSMENT OF CASE REPORTS
Open this folder and view contents8. USE OF THE DATA
Open this folder and view contents9. RELATIONS WITH OTHER PARTIES
View the document10. OTHER SOURCES OF INFORMATION
View the document11. FUNDING
View the documentREFERENCES
View the documentGLOSSARY
View the documentCAUSALITY CATEGORIES
View the documentWHO CONTACTS
 

5.2 Stimulation of reporting

The reporting of adverse reactions needs continuous stimulation. It is important to achieve the development of a positive attitude towards pharmacovigilance among healthcare professionals so that adverse reaction reporting becomes an accepted and understood routine. In summary, the following may stimulate reporting:

• easy access to pre-paid reporting forms and other means of reporting

• acknowledging the receipt of adverse drug reaction reports by personal letter or phone call

• providing feedback to reporters in the form of articles in journals, adverse drug reaction bulletins or newsletters

• participation of the centres staff in pre- and postgraduate education and scientific meetings

• collaboration with local drug or pharmacovigilance committees

• collaboration with professional associations

• integration of pharmacovigilance in the (further) development of clinical pharmacy and clinical pharmacology in a country.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017